eicosapentaenoic acid ethyl ester has been researched along with pioglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, K; Hirako, S; Iizuka, Y; Kim, H; Matsumoto, A; Wada, M | 1 |
| Lee, M; Ovbiagele, B; Saver, JL | 1 |
2 other study(ies) available for eicosapentaenoic acid ethyl ester and pioglitazone
| Article | Year |
|---|---|
Benefits of combination low-dose pioglitazone plus fish oil on aged type 2 diabetes mice.
Topics: Aging; Animals; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids; Fish Oils; Humans; Hypoglycemic Agents; Insulin; Lipogenesis; Liver; Male; Mice; Pioglitazone | 2018 |
Intensive Medical Management to Prevent Large and Small Artery Atherothrombotic Stroke: Time to Expand the Horizon.
Topics: Eicosapentaenoic Acid; Folic Acid; Glucagon-Like Peptide-1 Receptor; Humans; Hyperlipidemias; Hypoglycemic Agents; Insulin Resistance; Pioglitazone; Thrombotic Stroke | 2021 |